Announcements Trials
Browse Landscape

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Plasma cell 1Other 1

Conditions

Cardiotoxicity 14Breast Neoplasms 10Neoplasms 4Heart Failure 4Heart Diseases 2Cardiovascular Diseases 2Ventricular Dysfunction, Left 1Ventricular Dysfunction 1Thoracic Neoplasms 1Radiation Injuries 1Prostatic Neoplasms 1Peritoneal Neoplasms 1Myeloproliferative Disorders 1Multiple Myeloma 1Metabolic Syndrome 1Memory Disorders 1Melanoma 1Lymphoma, Non-Hodgkin 1Lymphoma, Follicular 1Leukemia, Lymphocytic, Chronic, B-Cell 1Hereditary Breast and Ovarian Cancer Syndrome 1Dyspnea 1Dyslipidemias 1Cognitive Dysfunction 1Central Nervous System Neoplasms 1Cardiomyopathies 1Carcinoma, Non-Small-Cell Lung 1Breast Neoplasms, Male 1Bone Neoplasms 1Atherosclerosis 1

Interventions

Surveys and Questionnaires 5Dexamethasone 2Calcium Dobesilate 2dexamethasone acetate 1dexamethasone 21-phosphate 1auricularum 1Tiotropium Bromide 1Sugars 1Standard of Care 1Respiratory Therapy 1Rehabilitation 1Oxygen 1Midazolam 1Losartan 1Lisinopril 1Hypnosis 1Hematologic Tests 1Furosemide 1Fentanyl 1Exercise 1Educational Status 1Echocardiography 1Dexmedetomidine 1Buspirone 1Behavior Therapy 1Aromatherapy 1Acupuncture Therapy 1Acupressure 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Dyspnea × Echocardiography × Clear all
NCT04827563 2026-03-04

Dyspnea and Cardiotoxicity in Multiple Myeloma Patients Who Receive Carfilzomib

University of Chicago

Terminated
50 enrolled
OtherPlasma cell

Dyspnea, Multiple Myeloma, Cardiotoxicity

Data powered by HemOnc (CC BY 4.0) Colophon âš¡